The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner. 2005

Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
Seattle Biomedical Research Institute, 307 Westlake Avenue North, Seattle, WA 98109, USA.

It is well documented that removal of the V1V2 region or of the V2 loop alone from the envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1) or simian immunodeficiency virus (SIV) increases the susceptibility of these viruses to neutralization by antibodies. The specific role of the V1 loop in defining the neutralization susceptibility of HIV is, however, not well documented. Our current studies indicate that although the V1V2 region is a global modulator of the HIV-1 neutralization susceptibility, the individual roles the V1 and V2 loops have in defining the neutralization susceptibility profile of HIV-1 differ and in some cases are opposite. While deletion of the V2 loop renders the virus more susceptible to neutralization by antibodies that recognize diverse epitopes, in particular certain ones located in the CD4 binding site and the V3 loop, deletion of the V1 loop renders the virus refractory to neutralization, especially by antibodies that recognize CD4-induced epitopes and certain CD4-site binding antibodies. Our current studies also indicate that the relative involvement of the V2 loop of the HIV-1 envelope during virus-cell entry appears to be envelope background dependent. As a result, although deletion of the V2 loop from the clade B, R5-tropic SF162 HIV-1 virus resulted in a virus that was replication competent, the same modification introduced on the background of two other R5-tropic isolates, SF128A (clade B) or SF170 (clade A), abrogated the ability of these envelopes to mediate virus-cell entry.

UI MeSH Term Description Entries
D008561 Membrane Fusion The adherence and merging of cell membranes, intracellular membranes, or artificial membranes to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes. Fusion, Membrane,Fusions, Membrane,Membrane Fusions
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
January 2009, Journal of virology,
Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
June 1993, Journal of virology,
Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
October 1995, Virology,
Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
January 1998, AIDS research and human retroviruses,
Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
April 1994, Molecular immunology,
Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
January 1994, Journal of virology,
Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
April 1995, Journal of virology,
Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
July 2001, Journal of virology,
Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
April 2005, Journal of virology,
Cheryl J Saunders, and Ruth A McCaffrey, and Irina Zharkikh, and Zane Kraft, and Susan E Malenbaum, and Brian Burke, and Cecilia Cheng-Mayer, and Leonidas Stamatatos
June 2001, Journal of virology,
Copied contents to your clipboard!